Design
Review
Authors
Loading...
Supports prioritizing intrarenal angiotensin II blockade in ACE inhibitor use; extends mechanistic data but leaves open clinical translation.
Key points are not available for this paper at this time.
John E. Hall (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: